Cite

HARVARD Citation

    Navari, R. et al. (n.d.). Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapy. Cancer medicine. pp. 2943-2950. [Online]. 
  
Back to record